18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Intellectual Disability (ID) is a clinically heterogeneous condition that affects 2–3% of population worldwide. In recent years, exome sequencing has been a successful strategy for studies of genetic causes of ID, providing a growing list of both candidate and validated ID genes. In this study, exome sequencing was performed on 28 ID patients in 27 patient‐parent trios with the aim to identify de novo variants (DNVs) in known and novel ID associated genes. We report the identification of 25 DNVs out of which five were classified as pathogenic or likely pathogenic. Among these, a two base pair deletion was identified in the PUF60 gene, which is one of three genes in the critical region of the 8q24.3 microdeletion syndrome (Verheij syndrome). Our result adds to the growing evidence that PUF60 is responsible for the majority of the symptoms reported for carriers of a microdeletion across this region. We also report variants in several genes previously not associated with ID, including a de novo missense variant in NAA15. We highlight NAA15 as a novel candidate ID gene based on the vital role of NAA15 in the generation and differentiation of neurons in neonatal brain, the fact that the gene is highly intolerant to loss of function and coding variation, and previously reported DNVs in neurodevelopmental disorders.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          A de novo paradigm for mental retardation.

          The per-generation mutation rate in humans is high. De novo mutations may compensate for allele loss due to severely reduced fecundity in common neurodevelopmental and psychiatric diseases, explaining a major paradox in evolutionary genetic theory. Here we used a family based exome sequencing approach to test this de novo mutation hypothesis in ten individuals with unexplained mental retardation. We identified and validated unique non-synonymous de novo mutations in nine genes. Six of these, identified in six different individuals, are likely to be pathogenic based on gene function, evolutionary conservation and mutation impact. Our findings provide strong experimental support for a de novo paradigm for mental retardation. Together with de novo copy number variation, de novo point mutations of large effect could explain the majority of all mental retardation cases in the population.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency.

            We have identified two families with a previously undescribed lethal X-linked disorder of infancy; the disorder comprises a distinct combination of an aged appearance, craniofacial anomalies, hypotonia, global developmental delays, cryptorchidism, and cardiac arrhythmias. Using X chromosome exon sequencing and a recently developed probabilistic algorithm aimed at discovering disease-causing variants, we identified in one family a c.109T>C (p.Ser37Pro) variant in NAA10, a gene encoding the catalytic subunit of the major human N-terminal acetyltransferase (NAT). A parallel effort on a second unrelated family converged on the same variant. The absence of this variant in controls, the amino acid conservation of this region of the protein, the predicted disruptive change, and the co-occurrence in two unrelated families with the same rare disorder suggest that this is the pathogenic mutation. We confirmed this by demonstrating a significantly impaired biochemical activity of the mutant hNaa10p, and from this we conclude that a reduction in acetylation by hNaa10p causes this disease. Here we provide evidence of a human genetic disorder resulting from direct impairment of N-terminal acetylation, one of the most common protein modifications in humans. Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Diagnostic genome profiling in mental retardation.

              Mental retardation (MR) occurs in 2%-3% of the general population. Conventional karyotyping has a resolution of 5-10 million bases and detects chromosomal alterations in approximately 5% of individuals with unexplained MR. The frequency of smaller submicroscopic chromosomal alterations in these patients is unknown. Novel molecular karyotyping methods, such as array-based comparative genomic hybridization (array CGH), can detect submicroscopic chromosome alterations at a resolution of 100 kb. In this study, 100 patients with unexplained MR were analyzed using array CGH for DNA copy-number changes by use of a novel tiling-resolution genomewide microarray containing 32,447 bacterial artificial clones. Alterations were validated by fluorescence in situ hybridization and/or multiplex ligation-dependent probe amplification, and parents were tested to determine de novo occurrence. Reproducible DNA copy-number changes were present in 97% of patients. The majority of these alterations were inherited from phenotypically normal parents, which reflects normal large-scale copy-number variation. In 10% of the patients, de novo alterations considered to be clinically relevant were found: seven deletions and three duplications. These alterations varied in size from 540 kb to 12 Mb and were scattered throughout the genome. Our results indicate that the diagnostic yield of this approach in the general population of patients with MR is at least twice as high as that of standard GTG-banded karyotyping.
                Bookmark

                Author and article information

                Contributors
                lars.feuk@igp.uu.se
                Journal
                Am J Med Genet B Neuropsychiatr Genet
                Am. J. Med. Genet. B Neuropsychiatr. Genet
                10.1002/(ISSN)1552-485X
                AJMG
                American Journal of Medical Genetics
                John Wiley and Sons Inc. (Hoboken )
                1552-4841
                1552-485X
                09 October 2017
                January 2018
                : 177
                : 1 ( doiID: 10.1002/ajmg.b.v177.1 )
                : 10-20
                Affiliations
                [ 1 ] Department of Immunology Genetics and Pathology Science for Life Laboratory Uppsala Uppsala University Uppsala Sweden
                [ 2 ] Department of Molecular Medicine and Surgery Karolinska Institute Karolinska University Hospital Solna Stockholm Sweden
                [ 3 ] Department of Pediatrics Örebro University Hospital Örebro Sweden
                [ 4 ] Pediatric Clinic Falun Sweden
                [ 5 ] Department of Pediatrics Gävle Hospital Gävle Sweden
                [ 6 ] Department of Clinical Genetics, and Department of Clinical Medicine Linköping University Linköping Sweden
                Author notes
                [*] [* ] Correspondence

                Dr. Lars Feuk, Department of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Box 815, BMC B11:4, Uppsala University, SE‐751 08 Uppsala, Sweden.

                Email: lars.feuk@ 123456igp.uu.se

                Author information
                http://orcid.org/0000-0001-8367-8391
                Article
                AJMGB32574
                10.1002/ajmg.b.32574
                5765476
                28990276
                33226de2-8512-4f54-ba58-653325e24da6
                © 2017 The Authors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Published by Wiley Periodicals, Inc.

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 28 December 2016
                : 09 May 2017
                : 05 July 2017
                Page count
                Figures: 2, Tables: 4, Pages: 11, Words: 5700
                Funding
                Funded by: European Research Council
                Funded by: Medicinska Forskningsrådet
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                ajmgb32574
                January 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.8 mode:remove_FC converted:12.01.2018

                Genetics
                exome sequencing,intellectual disability,naa15,puf60
                Genetics
                exome sequencing, intellectual disability, naa15, puf60

                Comments

                Comment on this article